Adverse events
| System organ class preferred term | Pooled AM (n=12) n (%) | Pooled PM (n=12) n (%) | All (n=12) n/% |
|---|---|---|---|
| Number of AEs/number of subjects (% of subjects with ≥1 AE) | 2/2 (16.7) | 11/6 (50.0) | 13/7 (58.3) |
| Eye disorders | 0 (0.0) | 6 (50.0) | 6 (50.0) |
| Dry eye | 0 (0.0) | 3 (25.0) | 3 (25.0) |
| Eye pruritus | 0 (0.0) | 1 (8.3) | 1 (8.3) |
| Ocular hyperaemia | 0 (0.0) | 6 (50.0) | 6 (50.0) |
| Gastrointestinal disorders | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| Dyspepsia | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| Skin and subcutaneous tissue disorders | 1 (8.3) | 1 (8.3) | 2 (16.7) |
| Dermatitis contact | 0 (0.0) | 1 (8.3) | 1 (8.3) |
| Urticaria | 1 (8.3) | 0 (0.0) | 1 (8.3) |
AE, adverse event.